oxygen(2-);samarium(3+)

Names

[ CAS No. ]:
12060-58-1

[ Name ]:
oxygen(2-);samarium(3+)

[Synonym ]:
MFCD00011237
EINECS 235-043-6
Samarium(III) oxide
oxygen(2-),samarium(3+)
Samarium Oxide

Chemical & Physical Properties

[ Density]:
8.347

[ Melting Point ]:
2325ºC

[ Molecular Formula ]:
O₃Sm₂

[ Molecular Weight ]:
348.718

[ Exact Mass ]:
351.824158

[ PSA ]:
43.37000

[ Index of Refraction ]:
1.97

MSDS

Click to get detail MSDS

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :: VP3153000

CHEMICAL NAME :: Samarium oxide

CAS REGISTRY NUMBER :: 12060-58-1

LAST UPDATED :: 199701

DATA ITEMS CITED :: 2

MOLECULAR FORMULA :: O3-Sm2

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: >5 gm/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: ATDAEI Acute Toxicity Data. Journal of the American College of Toxicology, Part B. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1- 1990- Volume(issue)/page/year: 12,627,1993

Safety Information

[ Personal Protective Equipment ]:
Eyeshields;Gloves

[ Hazard Codes ]:
T+

[ Safety Phrases ]:
S22-S24/25

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
2

[ RTECS ]:
VP3153000

[ HS Code ]:
2846901940

Customs

[ HS Code ]: 2846901940

Articles

Neutron activation based gamma scintigraphic evaluation of enteric-coated capsules for local treatment in colon.

Int. J. Pharm. 349(1-2) , 24-9, (2008)

The fate of two colon-specific formulations developed in our previous study was investigated using a gamma scintigraphic imaging method. The formulations contained paracetamol and samarium oxide (Sm2O...

Neutron activation-based gamma scintigraphy in pharmacoscintigraphic evaluation of an Egalet constant-release drug delivery system.

Int. J. Pharm. 281(1-2) , 3-10, (2004)

This paper is a report from a pharmacoscintigraphic study with an Egalet constant-release system containing caffeine and natural abundance samarium oxide. First the formulation was tested in vitro to ...

Oral delivery of antisense oligonucleotides in man.

J. Pharm. Sci. 97(1) , 225-36, (2008)

Treatment of systemic disease with phosphorothioate antisense oligonucleotides (PS ASOs) has been accomplished using local or parenteral routes of administration to date. This report describes, for th...